Ibrance 75 MG tablet 7S
Ended Awarded
- Contract number
- SPE2DB25FWZGE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,124
Award facts
- Contract value 100% obligated
- $8,123.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $8,123.96 to supply Ibrance 75 mg tablets (quantity 7) with a firm fixed price structure. This non-set-aside, competitively awarded contract is designated as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 8, 2025.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen leverages its comprehensive IDC vehicle to fulfill diverse pharmaceutical supply needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Ibrance, a brand-name oncology medication, represents the type of specialized pharmaceutical commodity that AmerisourceBergen routinely delivers through its DLA contracts. The company's extensive portfolio of federal awards demonstrates consistent capability to meet competitive procurement requirements across multiple therapeutic domains, from specialty medications to generic drugs and medical devices supporting military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DB25FWZGE?
SPE2DB25FWZGE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 15, 2025.
How much is contract SPE2DB25FWZGE worth?
The government has obligated $8,124 on SPE2DB25FWZGE.
Is contract SPE2DB25FWZGE an order under another contract?
Yes. SPE2DB25FWZGE is a delivery order under SPE2DB25D3012, an indefinite delivery contract.
Was contract SPE2DB25FWZGE competed?
The extent of competition for SPE2DB25FWZGE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award